Recruiting NA INTERVENTIONAL 2-arm NCT06282042

Early Transcatheter Mitral Valve Repair After Myocardial Infarction (EMCAMI)

Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias

Interventions Early transcatheter edge-to-edge mitral valve repair (TEER). MitraClip Optimal medical treatment

Updated 6 times since 2024 Last updated: Oct 15, 2025 Started: Dec 24, 2024 Primary completion: Jun 16, 2027 Completion: Jun 16, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Mitral Regurgitation and is currently actively recruiting participants. Fundación para la Investigación Biosanitaria del Principado de Asturias leads this study, which shows 6 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Nov 2025 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting · Phase: PHASE4 → NA
Sep 2025 — Nov 2025 [monthly]

Not Yet Recruiting PHASE4
Sep 2024 — Sep 2025 [monthly]

Not Yet Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Mar 2024 — May 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación para la Investigación Biosanitaria del Principado de Asturias
Meditrial Europe Ltd.

Data source: Fundación para la Investigación Biosanitaria del Principado de Asturias

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Afula, Israel , Alicante, Spain , Amsterdam, Netherlands , Barcelona, Spain , Breda, Netherlands , Brescia, Italy , Córdoba, Spain , Eindhoven, Netherlands , Genova, Italy , Jerusalem, Israel and 17 more locations